Fueling the Future of Cardiovascular Health
Your support of the Cardiovascular Service Line at the University of Utah shapes the future of medicine. Together, we can accelerate breakthroughs, train specialized clinicians, and transform patient care in the Intermountain West and beyond.
The Urgent Need
Cardiovascular disease is the leading cause of death in the United States, claiming over 915,000 lives annually. Heart disease and stroke kill more Americans than cancer and accidents combined—with a life lost every 34 seconds.
With heart failure costing $70 billion annually in the U.S. and $400 billion globally, philanthropic investment here positions the University of Utah as a primary international driver of medical innovation and life-saving care.
A Legacy of Discovery
The University of Utah is built on a proud foundation of medical “firsts” that have fundamentally changed global medicine:
- The Jarvik Heart: Home of the world’s first permanent artificial heart (Jarvik-7) and a global leader in mechanical heart support.
- Long QT Syndrome: Discovered at the U of U, this was the first identified genetic heart abnormality, leading to the removal of several dangerous drugs from the global market.
- Advanced Cardiac Mapping: Pioneered revolutionary body surface mapping and catheter ablation to pinpoint and treat complex arrhythmias.
Featured Opportunities to Support
The Roger A. Freedman Endowment in Cardiovascular Medicine
Dr. Jared Bunch Development Fund
Dr. Josef Stehlik Development Fund
